Orin Hirschman and AIGH Capital Management Reduce Stake in Grace Therapeutics to 4.9%

On April 27, 2026, Orin Hirschman and AIGH Capital Management LLC filed a Schedule 13G/A (Amendment No. 4) regarding their holdings in Grace Therapeutics, Inc. (GRCE). The filing reports that as of March 31, 2026, the reporting persons beneficially own 814,000 shares of common stock, representing 4.9% of the company. This indicates a decrease from their previously reported position of 907,217 shares and a 5.9% ownership stake. The reported 814,000 shares are comprised entirely of common shares issuable upon the exercise of warrants. An additional 10,742 shares issuable upon exercise of warrants were excluded from the beneficial ownership calculation due to contractual limitations. Orin Hirschman serves as the Managing Member of AIGH Capital Management LLC and President of AIGH LLC, exercising dispositive power over the shares held by these entities and his family. The filing confirms that the securities were acquired in the ordinary course of business without the intent to influence or change the control of the issuer.